Cerevel Therapeutics Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.66 | -$0.66 | -$0.66 |
| Q2 2024 | 3 | -$0.92 | -$0.56 | -$0.76 |
| Q3 2024 | 1 | -$0.73 | -$0.73 | -$0.73 |
| Q4 2024 | 1 | -$0.85 | -$0.85 | -$0.85 |
| Q1 2025 | 1 | -$0.72 | -$0.72 | -$0.72 |
| Q2 2025 | 1 | -$0.73 | -$0.73 | -$0.73 |
| Q3 2025 | 1 | -$0.76 | -$0.76 | -$0.76 |
Cerevel Therapeutics Holdings, Inc. Earnings Date And Information
Cerevel Therapeutics Holdings, Inc. last posted its earnings results on Wednesday, August 7th, 2024. The company reported $-0.63 earnings per share for the quarter, missing analysts' consensus estimates of $-0.61 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Cerevel Therapeutics Holdings, Inc. has generated $-3 earnings per share over the last year ($-2.67 diluted earnings per share) and currently has a price-to-earnings ratio of -17.73. Cerevel Therapeutics Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based on prior year's report dates.
Cerevel Therapeutics Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/08/2024 | Q1 2024 | -$0.66 | -$0.73 | -0.07 | $0 | $0 |
| 04/26/2024 | Q4 2023 | -$0.76 | $8.25 M | |||
| 11/01/2023 | Q3 2023 | -$0.63 | -$0.61 | 0.02 | $0 | |
| 08/02/2023 | Q2 2023 | -$0.65 | -$0.63 | 0.02 | $0 | |
| 05/03/2023 | Q1 2023 | -$0.67 | -$0.67 | 0 | $0 | |
| 02/22/2023 | Q4 2022 | -$0.64 | -$0.59 | 0.05 | $0 | |
| 11/08/2022 | Q3 2022 | -$0.62 | -$0.69 | -0.07 | $0 | |
| 08/01/2022 | Q2 2022 | -$0.50 | -$0.61 | -0.11 | $0 | |
| 05/10/2022 | Q1 2022 | -$0.44 | -$0.43 | 0.01 | $0 | |
| 03/01/2022 | Q4 2021 | -$0.41 | -$0.40 | 0.01 | $0 | |
| 11/10/2021 | Q3 2021 | -$0.40 | -$0.43 | -0.03 | $0 | |
| 08/11/2021 | Q2 2021 | -$0.41 | -$0.42 | -0.01 | $0 | |
| 05/17/2021 | Q1 2021 | -$0.45 | -$0.40 | 0.05 | $0 | |
| 03/24/2021 | Q4 2020 | -$0.37 | -$0.30 | 0.07 | $0 | |
| 11/16/2020 | Q3 2020 | -$0.31 | $0 | |||
| 08/14/2020 | Q2 2020 | -$0.21 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.42 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.35 | $0 | |||
| 09/29/2019 | Q3 2019 | -$7.73 | $0 | |||
| 06/29/2019 | Q2 2019 | -$1.26 | $0 |
Cerevel Therapeutics Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Cerevel Therapeutics Holdings, Inc.'s earnings date?
Cerevel Therapeutics Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates.
-
How can I listen to Cerevel Therapeutics Holdings, Inc.'s earnings conference call?
The conference call for Cerevel Therapeutics Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Cerevel Therapeutics Holdings, Inc.'s conference call transcript?
The conference call transcript for Cerevel Therapeutics Holdings, Inc.'s latest earnings report can be read online.
-
How much profit does Cerevel Therapeutics Holdings, Inc. generate each year?
Cerevel Therapeutics Holdings, Inc. (:CERE) has a recorded net income of $0. Cerevel Therapeutics Holdings, Inc. has generated $-2.67 earnings per share over the last four quarters.
-
What is Cerevel Therapeutics Holdings, Inc.'s price-to-earnings ratio?
Cerevel Therapeutics Holdings, Inc. (:CERE) has a price-to-earnings ratio of -17.73 and price/earnings-to-growth ratio is 7.89.
